- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT04003571
Effectiveness of Interactive Augmented Reality and Electrical Neuromodulation System in Persons With Stroke
10 december 2019 uppdaterad av: Lai chien hung, Taipei Medical University Hospital
Development of Interactive Augmented Reality and Electrical Neuromodulation System to Improve Neuroplasticity and Limbs Function in Persons With Stroke
This study is to investigate the effects of Augmented Reality (AR) combined with Functional Electrical Stimulation (FES) intervention on cortical excitability, brain structure, lower limbs function, balance, and spasticity in individuals with stroke.
Twenty participants will be recruited in this study.
They will be allocated to two group: AR and FES group (10), Traditional physiotherapy group (10).
Studieöversikt
Status
Okänd
Betingelser
Intervention / Behandling
Detaljerad beskrivning
Participants will be randomized allocated to two groups: Augmented Reality and Functional Electrical Stimulation group , and traditional physiotherapy group.
All participants will undergo 60 minutes per session, 3 sessions per week for 8 weeks training.
Functional Magnetic Resonance Imaging (fMRI) with Diffusion Tensor Imaging (DTI), Time up go test (TUG), Berg Balance Scale (BBS), Fugl-Meyer Assessment (FMA), Modified Ashworth Scale (MAS), 10 meter walking test will be assessed before and after intervention in all participants.
Studietyp
Interventionell
Inskrivning (Förväntat)
20
Fas
- Inte tillämpbar
Kontakter och platser
Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.
Studieorter
-
-
-
Taipei, Taiwan
- Rekrytering
- Taipei Medical University Hospital
-
-
Deltagandekriterier
Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.
Urvalskriterier
Åldrar som är berättigade till studier
20 år till 80 år (Vuxen, Äldre vuxen)
Tar emot friska volontärer
Nej
Kön som är behöriga för studier
Allt
Beskrivning
Inclusion Criteria:
- Patients present with unilateral hemiplegia caused by a first-ever stroke
- Brunnstrom stage above stage II, mental health was stable
- Cognitive ability is sufficient to understand the nature of study (Mini-Mental State Examination score was above 23)
Exclusion Criteria:
- Patients having other neurologic problems, which can affect balance and walking ability
- Intake of drugs or other medical condition that can affect function or can't tolerate rehabilitation
- severe hearing or eye problem
Studieplan
Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Behandling
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Enda
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: Augmented reality with functional electrical stimulation group
Ten participants in group A will undergo 30 minutes interactive augmented reality with functional electrical stimulation intervention and 30 minutes traditional physiotherapy per day, 3 days a week for 8 weeks.
|
Experimental group contains 30 minutes augmented reality combined with functional electrical stimulation training, and 30 minutes traditional physiotherapy.
Augmented reality includes treadmill and balance exercise.
Functional electrical stimulation applies on tibialis anterior muscle.
Traditional physiotherapy includes rolling, sitting, standing, overground walking, facilitation of the paretic limbs, and so on.
|
|
Aktiv komparator: Traditional physiotherapy group
Ten participants in group B will undergo 30 minutes treadmill and balance training as well as 30 minutes traditional conventional physiotherapy a day, 3 days a week, for 8 weeks.
|
Traditional physiotherapy includes treadmill and balance training for 30 minutes as well as rolling, sitting, standing, overground walking, facilitation of the paretic limbs for another 30 minutes .
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Change of Time Up Go test (TUG)
Tidsram: Measurement before and after intervention ( week 0 and at the end of week 8) in both groups
|
The TUG test will ask participants to stand up, walk for 3 meters, turn, walk back and sit down as fast as they can during the test, and the time requires for each patient to complete the test is recorded.
|
Measurement before and after intervention ( week 0 and at the end of week 8) in both groups
|
|
Change of Berg Balance Scale (BBS)
Tidsram: Measurement before and after intervention ( week 0 and at the end of week 8) in both groups
|
Participants performed a series of 14 functional balance tasks, including maintaining a quiet stance, sitting-to-standing, shifting weight and reaching, turning in place, standing on one leg, and maintaining a tandem stance.
Each task was scored on a 5-point ordinal scale (from 0 to 4).
A score of 0 denotes the inability of the participant to perform the task, and a score of 4 denotes that the participant can complete the task based on a preset criterion.
The highest possible score is 56.
|
Measurement before and after intervention ( week 0 and at the end of week 8) in both groups
|
|
Change of Functional magnetic resonance imaging (fMRI)
Tidsram: Measurement before and after intervention ( week 0 and at the end of week 8) in both groups
|
Our study will use 3 Tesla magnetic resonance imaging[GE DISCOVERY MR750w system (GE Healthcare, Milwaukee, Wisconsin)] for functional magnetic resonance imaging.
Resting-state functional MRI image is an echo-planar Image (EPI) technique, using a parameter time of repetition of 2500 milliseconds, time of echo is 30 milliseconds, 43 axial slices,slice thickness is 3 mm, flip angle is 80 degrees, field of view is 192 x 192 millimeters, and vixen size is 3 x 3 x 3 millimeters.
The EPI scan for 525 seconds.
All subjects are asked to close their eyes and supine.
our study uses the fractional amplitude of low-frequency fluctuations analysis to confirm abnormal brain function.
|
Measurement before and after intervention ( week 0 and at the end of week 8) in both groups
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Change of Fugl-Meyer Assessment (FMA)-Lower extremity
Tidsram: Measurement before and after intervention ( week 0 and at the end of week 8) in both groups
|
Fugl-Meyer Assessment-Lower extremity is used to measure lower-limb recovery in stroke rehabilitation studies.The scale has 6 items ranging from reflex activity to voluntary motor control.
Each item further comprises components, with a total of 17. Scoring is done on a 3-point ordinal scale ranges from 0 (no performance) to 2 (faultless performance).
The total score range from 0 (no motor function) to 34 (good motor recovery).
|
Measurement before and after intervention ( week 0 and at the end of week 8) in both groups
|
|
Change of Modified Ashworth Scale (MAS)
Tidsram: Measurement before and after intervention ( week 0 and at the end of week 8) in both groups
|
Modified Ashworth scale (MAS) measures resistance during passive soft-tissue stretching and is used as a simple measure of spasticity. Scoring is recorded as follows: 0: No increase in muscle tone
|
Measurement before and after intervention ( week 0 and at the end of week 8) in both groups
|
|
Change of Motor evoked potential (MEP)
Tidsram: Measurement before and after intervention ( week 0 and at the end of week 8) in both groups
|
Motor evoked potential (MEP) is recorded from tibialis anterior muscles following direct transcranial magnetic stimulation (TMS) of motor cortex.
All TMS is delivered with the participant seated upright on the chair.
Both passive and active conditions, participants are instructed to relax their right leg in the seated position.
TMS is delivered over the motor cortex (M1) using a concave double cone coil (Magstim Co., United Kingdom) attached to a BiStim magnetic stimulator (Magstim Co., United Kingdom).
To locate the optimal site, stimuli are delivered over various points along the M1.
The optimal site is the location on the M1 that evoked the greatest MEP amplitude in the bilateral tibialis anterior muscles.
The onset latency and onset to peak amplitude will be assessed.
|
Measurement before and after intervention ( week 0 and at the end of week 8) in both groups
|
|
Change of 10 meter walking test
Tidsram: Measurement before and after intervention ( week 0 and at the end of week 8) in both groups
|
Individual walks without assistance 10 meters and the time is measured.
Participants will walk 10 meter at preferred walking speed and fastest speed possible, respectively.
|
Measurement before and after intervention ( week 0 and at the end of week 8) in both groups
|
|
Change of Diffusion Tensor Imaging (DTI)
Tidsram: Measurement before and after intervention ( week 0 and at the end of week 8) in both groups
|
Diffusion tensor imaging technique apply to Echo-Planar Image(EPI) technique, fimbriodentate vein is 192X192 mm², time of repetition/time of echo is 11000/110.6
mm, matrix is 72X72 pixels, slice thickness is 2.7 mm. Diffusion weight gradient along 60 directions at b value of 3000/mm².
By observing the reduction of the degree of diffusion anisotropy, to study the recovery of motor function after stroke.
|
Measurement before and after intervention ( week 0 and at the end of week 8) in both groups
|
Samarbetspartners och utredare
Det är här du hittar personer och organisationer som är involverade i denna studie.
Studieavstämningsdatum
Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.
Studera stora datum
Studiestart (Faktisk)
10 oktober 2019
Primärt slutförande (Förväntat)
31 december 2020
Avslutad studie (Förväntat)
15 mars 2021
Studieregistreringsdatum
Först inskickad
27 juni 2019
Först inskickad som uppfyllde QC-kriterierna
28 juni 2019
Första postat (Faktisk)
1 juli 2019
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
13 december 2019
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
10 december 2019
Senast verifierad
1 december 2019
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- N201904041
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Nej
Studerar en amerikansk FDA-reglerad produktprodukt
Nej
produkt tillverkad i och exporterad från U.S.A.
Nej
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .